| YANA - YOU ARE NOT ALONE NOW PROSTATE CANCER SUPPORT SITE HOMEPAGE LINKS : EXPERIENCES : DISCUSSION FORUM : TROOP C : ABOUT US : JOIN US : UPDATE YOUR STORY : MAIL US Acknowledgment and thanks are due to Eric Taylor, Australian Mentor for YANA, who created this and the other Charts. | |||||||||||||
| TREATMENT EXPERIENCES
| Most people are looking for information about one specific type of treatment, so the stories are initially grouped and indexed by:
It is also possible to see some of the stories indexed by country of residence. In the case of the USA, some entries are indexed by State of residence. In time all will show State of residence. The link is PLACE NAME TABLE The stories of men newly diagnosed men are here These are the links to the stories by treatment:
| ||||||||||||
|
Primary
Treatment
|
Further treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
NEWLY
DIAGNOSED/UNDECIDED | |||||||||||||
Sep-09 | 59 | 2.4 | 6 | T1c | - | - | Jan-10 | ||||||
Sep-09 | 72 | 13.0 | 9 | T1c | - | - | Dec-09 | ||||||
Aug-09 | 59 | 4.1 | 6 | T1c | - | - | Jan-10 | ||||||
Oct-09 | 53 | 7.0 | 8 | T1c | - | - | Dec-09 | ||||||
Dec-09 | 62 | 4.7 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
Oct-09 | 46 | 4.1 | 7 | T1c | - | - | Jan-10 | ||||||
| Nov-09 |
50 |
6.3 |
6 |
T1c |
- |
- |
Jan-10 | ||||||
Jul-09 | 62 | 9.0 | 8 | T2 | Undecided | - | - | Aug-09 | |||||
|
Dec-09 |
48 |
6.4 |
6 |
T1c |
Undecided |
- |
- |
Dec-09 | |||||
Sep-09 | 54 | 12.0 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
| Sep-09 |
52 |
4.2 |
6 |
T1c |
Undecided |
- |
- |
Dec-09 | |||||
Jun-09 | 54 | 21.0 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
Jul-09 | 74 | 6.4 | 6 | T1c | - | - | Jan-10 | ||||||
Jul-09 | 64 | 6.8 | 6 | T1c | - | - | Dec-09 | ||||||
May-09 | 70 | 7.8 | 7 | T1c | - | - | Jan-10 | ||||||
Oct-09 | 65 | 5.0 | 6 | T1c | 6.6 | - | Jan-10 | ||||||
Jul-09 | 67 | 8.4 | 6 | T1c | Undecided | - | - | Oct-09 | |||||
Oct-09 | 70 | <2.0 | 7 | ? | Undecided | - | - | Oct-09 | |||||
Nov-09 | 49 | 1.99 | 6 | T1c | Undecided | - | - | Dec-09 | |||||
Nov-09 | 52 | 4.41 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
| Oct-09 |
63 |
14.1 |
6 |
T1c |
14.3 |
Cancer
free |
Jan-10 | ||||||
| Dec-09 |
70 |
3.92 |
6 |
T2c |
Undecided |
- |
- |
Jan-10 | |||||
Sep-09 | 62 | 6.1 | 6 | T1c | - | - | Jan-10 | ||||||
Jun-09 | 56 | 4.1 | 7 | T2c | Undecided | - | - | Oct-09 | |||||
Oct-09 | 53 | 4.2 | 6 | T1c | - | - | Jan-10 | ||||||
Dec-09 | 64 | 5.9 | 6 | T1c | Undecided | - | - | Jan-10 | |||||
Sep-09 | 53 | 4.6 | 9 | T1c | - | - | Jan-10 | ||||||
Sep-09 | 70 | 10.0 | 7 | T1c | Undecided | - | - | Nov-09 | |||||
Aug-09 | 65 | 3.3 | 8 | T2b | Undecided | - | - | Sep-09 | |||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
ACTIVE
SURVEILLANCE - WATCHFUL WAITING | |||||||||||||
Aug-08 | 63 | 6.83 | 6 | T1c | Active
Surveillance | 4.6 | - | Dec-09 | |||||
|
May-04 |
65 |
5.7 |
6 |
T1c |
Active
Surveillance | 2.5 |
Cancer
Free/BPH | Nov-09 | |||||
Dec-07 | 56 | 5.24 | 6 | T1c | Active
Surveillance | 3.99 | Cryotherapy | Feb-09 | |||||
Oct-05 | 49 | 2.1 | 6 | T1c | Active
Surveillance | 0.6 | Cancer
Free | Jan-10 | |||||
Aug-08 | 61 | 10.0 | 7 | T1c | Active
Surveillance | Undetec | Surgery | Jan-10 | |||||
| Mar-03 |
60 |
4.5 |
6 |
T1c |
Watch
& Wait |
8.4 |
Supplements |
Jul-09 | |||||
Jun-08 | 73 | 4.1 | 7 | T1b | Active
Surveillance | 0.50 | Cancer
Free | Dec-09 | |||||
Nov-08 | 56 | 3.3 | 6 | T1c | Active
Surveillance | 2.4 | Cancer
Free | Jan-10 | |||||
Jun-09 | 54 | 4.7 | 6 | T1b | Active
Surveillance | - | - | Dec-09 | |||||
| May-03 |
47 |
4.59 |
6 |
T1c |
Active
Surveillance |
6.21 |
AS |
Nov-09 | |||||
Oct-09 | 67 | 4.6 | 6 | T1c | Active
Surveillance | - | - | Jan-10 | |||||
Jul-06 | 67 | 12.8 | 6 | T1c | Active
Surveillance | 4.5 | Cancer
Free | Dec-09 | |||||
| Jul-99 |
53 |
5.4 |
6 |
T1c |
Alternative |
+-
2.0 |
Human
milk |
Sep-09 | |||||
Oct-02 | 52 | 6.7 | 5 | T1c | Active
Surveillance | 5.3 | Brachytherapy | Nov-09 | |||||
| Mar-04 |
64 |
6.0 |
7 |
T1c |
Watch
& Wait |
1.03 |
ProstRcision® |
Nov-09
| |||||
| Aug-08 |
67 |
9.77 |
7 |
T1c |
Active
Surveillance |
5.37 |
- |
Mar-09
| |||||
Apr-06 | 54 | 4.4 | 6 | T1c | Active
Surveillance | No
response to reminder | Mar-08 | ||||||
Dec-06 | 55 | 5.8 | 6 | T1c | Watch
Wait | 1.7 | Proton
Beam | Nov-09 | |||||
Aug-07 | 62 | 3.0 | 6 | T1c | Active
Surveillance | 2.8 | Surgery | Oct-08 | |||||
Nov-09 | 55 | 10.0 | 6 | T1c | Active
Surveillance | - | Cancer
Free | Dec-09 | |||||
Apr-06 | 66 | 6.0 | 6 | T1c | Watch
& Wait | 8.3 | Watch
& Wait | Nov-09 | |||||
Jun-00 | 72 | 5.6 | 6 | T1c | Watch
& Wait | 0.12 | ADT/IMRT | Oct-09 | |||||
Nov-08 | 67 | <
4.0 | 7 | T1a | Active
Surveillance | 0.86 | ActiveSurveillance | Dec-09 | |||||
Nov-07 | 57 | 5.4 | 6 | T1c | Active
Surveillance | 4.6 | - | Nov-09 | |||||
Jul-09 | 48 | 3.0 | 6 | T1c | Active
Surveillance | 0.40 | - | Sep-09 | |||||
Nov-09 | 67 | 5.0 | 6 | T1c | Active
Surveillance | - | - | Dec-09 | |||||
Jun-08 | 57 | 9.1 | 6 | T2b | Active
Surveillance | 7.5 | - | Feb-09 | |||||
Jun-02 | 59 | 2.2 | 7 | ? | Watch
Wait | 5.2 | Experimental
| Jul-09 | |||||
Jan-98 | 68 | 5.5 | 5 | T1c | Watch
Wait | 20.0 | Prostatsol | Jun-09 | |||||
|
Aug-96 |
54 |
7.2 |
7 |
T2b |
Watch & Wait |
5.20 |
Inter ADT - off |
Jan-10 | |||||
Oct-06 | 52 | 4.3 | 6 | T1c | Active
Surveillance | 4.6 | AS | Dec-09 | |||||
Oct-03 | 62 | 6.1 | 6 | T1c | Watch
& Wait/Prostasol | 3.4 | Brachytherapy | Sep-09 | |||||
Aug-06 | 57 | 15.0 | 5 | T1a | Active
Surveillance | 0.30 | Finasteride | Aug-09 | |||||
Nov-08 | 56 | 3.8 | 6 | T1c | Active
Surveillance | 3.01 | - | Jan-10 | |||||
May-08 | 58 | 7.7 | 6 | T1c | Active
Surveillance | 11.9 | Cancer
free | Dec-09 | |||||
Jul-07 | 52 | 4.5 | - | - | Active
Surveillance | 6.6 | Diet
& Lifestyle | Nov-08 | |||||
Nov-95 | 48 | 60.0 | 7 | T1c | Watch/Wait | Passed
on - RIP | Sep-07 | ||||||
Jan-94 | 58 | 20.0 | 5 | T2 | Active
Surveillance | Rising | Change
Lifestyle | May-09 | |||||
Jan-09 | 61 | 10.5 | 6 | T1c | Active
Surveillance | 11.3 | Herbs
and diet | Dec-09 | |||||
Jun-07 | 50 | 3.9 | 7 | T1c | Active
Surveillance | 2.0 | Diet/Exercise | Dec-08 | |||||
Mar-09 | 63 | 6.5 | ? | T1c | Active
Surveillance | 13.5 | - | Aug-09 | |||||
Jun-09 | 58 | 12.5 | 6 | T1c | Active
Surveillance | 5.2 | - | Oct-09 | |||||
Dec-08 | 61 | 1.54 | 6 | T2a | Active
Surveillance | 1.54 | - | Dec-09 | |||||
| Oct-00 |
64 |
7.3 |
? |
? |
Watch
Wait | 15.2 |
Watch & Wait |
Dec-09 | |||||
Feb-06 | 58 | 4.4 | 6 | T1c | Watch
Wait | 0.06 | Surgery | Oct-08 | |||||
| Nov-02 |
60 |
5.0 |
6 |
T1c |
Watch & Wait |
<0.1 | EBRT |
Feb-09 | |||||
|
May-05 |
61 |
1.4 |
6 |
T2b |
Watch
& Wait | 3.2 |
Watch
& Wait |
Jan-09 | |||||
Nov-08 | 57 | 4.7 | 6 | T1c | Active
Surveillance | 4.3 | Cancer
Free | Sep-09 | |||||
Nov-09 | 58 | 0.73 | 6 | T2a | Active
Surveillance | - | - | Dec-09 | |||||
| Oct-09 |
63 |
14.1 |
6 |
T1c |
Active
Surveillance | 14.3 |
Cancer
free |
Jan-10 | |||||
Jun-04 | 50 | 3.8 | 6 | T1c | Active
Surveillance | 3.4 | - | Sep-09 | |||||
Sep-09 | 62 | 6.1 | 6 | T1c | Active
Surveillance | - | - | Jan-10 | |||||
| Aug-05 |
51 |
6.5 |
6 |
T1c |
Watch
& Wait | 7.0 |
Alternative |
Jan-09 | |||||
Jan-98 | 76 | 11.0 | 6 | T1c | Watch
& Wait | Passed
on - RIP | Jul-00 | ||||||
Nov-05 | 54 | 0.50 | 6 | T1a | Active
Surveillance | 0.60 | Active
Surveillance | May-09 | |||||
|
Apr-05 |
66 |
2.14 |
6 |
T1c |
Watch
& Wait | 2.78 |
Watch
& Wait |
Oct-09 | |||||
Apr-08 | 59 | 3.2 | 6 | T1c | Active
Surveillance | 1.2 | Finasteride | May-09 | |||||
May-07 | 52 | 12.2 | 6 | T1c | Active
Surveillance | 37.0 | - | May-09 | |||||
Dec-09 | 62 | 3.9 | 6 | T1c | Active
Surveillance | - | - | Jan-10 | |||||
Jan-09 | 58 | 6.1 | 6 | T1c | Active
Surveillance | 2.5 | Proscar | Jul-09 | |||||
Oct-07 | 51 | 3.3 | 6 | T2a | Active
Surveillance | 2.3 | Surgery | Mar-09 | |||||
Feb-08 | 52 | 4.19 | 7 | T1c | Active
Surveillance | 1.7 | - | Dec-08 | |||||
Sep-09 | 40 | 1.4 | 6 | T1c | Active
Surveillance | - | Cancer
Free | Nov-09 | |||||
Oct-07 | 60 | 4.2 | 6 | T1c | Active
Surveillance | 2.6 | Cancer
Free | Feb-09 | |||||
Jan-08 | 52 | 0.90 | 6 | T1c | Active
Surveillance | 0.70 | - | Aug-09 | |||||
|
Nov-01 |
62 |
6.9 |
6 |
T1c |
Watch & Wait |
9.18 |
Vitamin-D |
Jan-09 | |||||
Feb-08 | 65 | 7.5 | 6 | T1c | Active
Surveillance | Unknown | ADT/EBRT/SI | Aug-09 | |||||
|
Feb-09 |
52 |
3.0 |
6 |
T1c |
Active
Surveillance |
3.2 |
- |
Aug-09 | |||||
Jan-06 | 54 | 5.2 | 6 | T1c | Watchful
Waiting | 7.1 | - | May-09 | |||||
Dec-96 | 76 | 8.7 | 7 | T1c | Watchful
Waiting | 49.6 | Finasteride | Aug-09 | |||||
Jul-08 | 69 | 4.6 | 6 | T2a | Active
Surveillance | 3.3 | - | Jan-09 | |||||
Mar-07 | 56 | 19.0 | 6 | T1c | Watchful
Waiting | 5.5 | Alkaline
Diet | Dec-09 | |||||
Nov-07 | 65 | 2.69 | 6 | T1c | Active
Surveillance | 5.0 | IMRT | May-09 | |||||
May-07 | 58 | 2.5 | 6 | T2a | Active
Surveillance | - | Focal
Cryotherapy | Oct-08 | |||||
|
Primary
Treatment
|
Further treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
ADT
- ANDROGEN DEPRIVATION THERAPY | |||||||||||||
Oct-08 | 40 | 41.0 | 8 | T4 | ADT | 1.01 | - | Jan-09 | |||||
Feb-07 | 55 | 9.0 | 9 | T4 | ADT | 0.38 | ADT | May-08 | |||||
Feb-07 | 55 | 9.0 | 9 | T4 | ADT | 165.0 | Jan-10 | ||||||
Sep-06 | 66 | 3,568 | ? | T4 | ADT | No
response to reminder | Jan-08 | ||||||
|
Jan-03 |
52 |
2,100 |
9 |
T4 |
ADT |
1,002.0 |
Red
Wine/ADT |
Sep-09 | |||||
Sep-07 | 64 | 62.3 | 9 | T3 | ADT | 0.40 | EBRT/ADT | Oct-09 | |||||
Oct-07 | 54 | 27.5 | 7 | T1c | ADT | 1.4 | ADT/EBRT/Chemo | Aug-09 | |||||
Jan-08 | 63 | 91.6 | 9 | T4 | ADT | 0.05 | ADT | Aug-09 | |||||
Mar-08 | 62 | 459.0 | 9 | T3 | ADT | 17.0 | - | Feb-09 | |||||
Apr-08 | 63 | 127.0 | ? | T4 | ADT | Passed
On - RIP | Sep-09 | ||||||
Feb-05 | 42 | 219.0 | 8 | T4 | ADT | 88.0 | Chemotherapy | Aug-09 | |||||
Dec-07 | 65 | 1,121.0 | 7 | T4 | ADT | 26.0 | Intermit
ADT | Dec-09 | |||||
Apr-07 | 45 | 31.0 | 8 | T4 | ADT | Passed
On - RIP | Dec-09 | ||||||
May-02 | 62 | 5.0 | 8 | T3 | EBRT/ADT | 5.0 | Trial | Nov-09 | |||||
Jun-05 | 78 | 11.1 | 7 | T2c | ADT | 0.10 | ADT | Jun-09 | |||||
Mar-06 | 48 | 433.0 | ? | T4 | ADT/Chemotherapy | Passed
On - RIP | Dec-07 | ||||||
Nov-07 | 57 | 10.0 | 8 | T4 | ADT | 0.75 |
- | Dec-08 | |||||
|
Dec-02 |
58 |
421.0 |
8 |
T4 |
ADT |
3.1 |
Chemotherapy |
Nov-08 | |||||
Jun-07 | 54 | 220.0 | 6 | T1c | ADT | Passed
On - RIP | Nov-08 | ||||||
Apr-09 | 72 | 47.0 | 9 | T4 | ADT | - | - | May-09 | |||||
Aug-08 | 62 | 299.0 | ? | T4 | ADT | - | - | Dec-09 | |||||
Feb-05 | 63 | 42.0 | 9 | T4 | ADT | 2.2 | TAK700
Trial | Nov-09 | |||||
Nov-08 | 52 | 2,520.0 | 9 | T4 | ADT | 19.6 | ADT | Feb-09 | |||||
Apr-07 | 68 | 4.0 | 9 | T4 | ADT | 8.7 | Chemo/Trial | Oct-08 | |||||
Jan-96 | 58 | 110.0 | 7 | T4 | ADT | 2.9
| ADT/Chemo | Nov-09 | |||||
Sep-06 | 82 | 35.0 | ? | T1c | ADT
(Orchiectomy) | <1.0 | ADT | Sep-08 | |||||
Aug-08 | 50 | 375.0 | 8 | D2 | ADT | 420.0 |
Chemotherapy | Nov-09 | |||||
Dec-08 | 47 | 1,500.0 | 9 | T4 | ADT | 33.4 |
Trial | Sep-09 | |||||
May-09 | 63 | 286.0 | 8 | T4 | ADT | 0.14 | - | Dec-09 | |||||
Mar-09 | 78 | 23.4 | 9 | T1c | ADT
(Eligard) | 1.4 | - | Jun-09 | |||||
Nov-08 | 72 | 42.0 | 8 | T1c | ADT/EBRT | - | - | Jan-09 | |||||
Jan-07 | 66 | 25.7 | 7 | T3 | Intermittent
ADT | 19.8 | Intermit
ADT | Mar-09 | |||||
Apr-07 | 56 | 960 | ? | T4 | ADT | 9.1 | ADT2 | Apr-09 | |||||
Sep-03 | 69 | 57.0 | 7 | T4 | ADT | Passed
On - RIP | Jun-08 | ||||||
Apr-08 | 58 | 98.0 | 8 | T4 | ADT | 6.5 | ADT/EBRT | Jan-10 | |||||
Feb-08 | 51 | 153.0 | 7 | T3b | ADT | 19.0
| Clinical
Trial | Jan-10 | |||||
Sep-07 | 65 | 4.6 | 9 | T3a | ADT/EBRT/Chemo/HDR | 0.03 | - | Aug-09 | |||||
Mar-09 | 50 | 179.0 | ? | T4 | ADT | 0.05
| - | Jan-10 | |||||
Mar-08 | 55 | 30.0 | 9 | T4 | ADT | 1.14 | ADT | Sep-09 | |||||
Oct-06 | 46 | 63.0 | 7 | T4M1 | ADT | Chemo
failed - mets spread | Jan-10 | ||||||
| Jan-05 |
50 |
206.6 |
9 |
T3 |
ADT | Passed
On - RIP | Nov-08 | ||||||
Jun-05 | 57 | 133.0 | 7 | T3a | ADT | 2,625.0 | EBRT/Drug
Trial | Jun-09 | |||||
|
May-09 |
51 |
362.0 |
9 |
T4 |
ADT | 128.0 | ADT3 |
Nov-09 | |||||
Jan-08 | 52 | 146.0 | 9 | T4 | ADT | 0.27 | Intermittent | Jan-09 | |||||
|
Dec-99 |
59 |
4,212.0 |
7 |
T4 | ADT | Passed
On - RIP | Aug-09 | ||||||
|
Jan-09 |
54 |
564.0 |
9 |
T4 |
ADT | 1.0 | ADT |
Aug-09 | |||||
|
Jun-09 |
69 |
42.0 |
8 |
T4 |
ADT | - | EBRT/ADT |
Oct-09 | |||||
Nov-98 | 68 | 14.6 | 6 | T1c | ADT | - | - | Nov-09 | |||||
May-06 | 57 | 70.0 | 10 | T3 | ADT | 0.05 | Intermit
ADT | Oct-09 | |||||
Oct-08 | 67 | 141.0 | 8 | T4 | ADT | 8.8 | ADT | Jul-09 | |||||
Jun-07 | 61 | 19.8 | 6 | T1c | Intermit
ADT3 | 5.88 | Diet
and herbs | Dec-09 | |||||
Aug-04 | 60 | 333.0 | 9 | T4 | ADT | 2.6 | ADT | Jun-09 | |||||
Dec-08 | 55 | 1,448.0 | ? | T4 | ADT | 13.3 |
ADT/Alternatives | Nov-09 | |||||
Aug-05 | 61 | 24.0 | 8 | T4M | ADT
| 1.60 | ADT/Natural | Dec-09 | |||||
Dec-08 | 65 | 13.0 | 8 | T4 | ADT
| 0.14 | EBRT/Brachytherapy | Nov-09 | |||||
Apr-09 | 75 | 1,892.0 | ? | T4 | ADT/Orchiectomy
| 401.0 | Off
ADT | Jan-10 | |||||
May-08 | 71 | 16.0 | ? | T3 | ADT
| - | ADT | Aug-09 | |||||
Jul-08 | 72 | 7,000.0 | 10 | T4 | ADT
| 4.5 | ADT | Oct-09 | |||||
Sep-06 | 59 | 435.0 | 9 | T4 | ADT | 734.0 | Chemotherapy | Dec-08 | |||||
Sep-08 | 39 | 68.0 | 9 | T4 | ADT
| <0.40 | ADT | Oct-09 | |||||
Jul-07 | 69 | 322.7 | 9 | T4 | ADT | No
response to reminder | Dec-07 | ||||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
RADIATION
- BRACHYTHERAPY | |||||||||||||
May-08 | 51 | 9.3 | 6 | T1c | Brachytherapy/EBRT | 3.2 | - | Jan-09 | |||||
Oct-09 | 46 | 4.1 | 7 | T1c | Brachytherapy | - | No
Problems | Feb-10 | |||||
Jun-05 | 67 | 11.0 | 6 | T2c | HDR
Brachytherapy | <0.05 | - | Oct-09 | |||||
Apr-07 | 52 | 4.98 | 6 | T1c | Brachytherapy | 3.20 | PSA
rising | Dec-09 | |||||
Aug-07 | 59 | 5.8 | 6 | T1c | Brachytherapy | 0.48 | - | Sep-09 | |||||
|
Jan-04 |
62 |
4.6 |
6 |
T1c |
Brachytherapy |
0.04 |
- |
May-09 | |||||
Jun-07 | 63 | 31.0 | 8 | T1c | Brachy/ADT/EBRT | <0.05
| - | Jan-09 | |||||
Oct-09 | 75 | 4.5 | 6 | T2b | Brachytherapy | - | - | Jan-10 | |||||
Aug-09 | 53 | 6.0 | 6 | T1c | Brachytherapy | - | - | Nov-09 | |||||
Apr-06 | 64 | 7.7 | 6 | T1c | Brachytherapy/IMRT | 0.087 | - | Feb-09 | |||||
Jul-09 | 64 | 6.8 | 6 | T1c | Brachytherapy | - | - | Dec-09 | |||||
Dec-08 | 73 | 10.5 | 9 | T1c | Brachytherapy/ADT | - | - | Jan-09 | |||||
Oct-09 | 61 | 4.78 | 6 | T1c | ADT/Brachytherapy | - | - | Dec-09 | |||||
May-09 | 70 | 7.8 | 7 | T1c | ADT/Brachytherapy | - | - | Jan-10 | |||||
Dec-05 | 66 | 8.7 | 8 | T1c | Brachytherapy | 0.01 | ED | Dec-09 | |||||
| Jan-04 |
66 |
4.0 |
6 |
T1c |
Brachtherapy |
No
response to reminder | Aug-08 | ||||||
May-05 | 69 | 4.7 | 6 | T1c | Brachytherapy | 0.45 | - | Nov-08 | |||||
Dec-07 | 47 | 3.6 | 6 | T1c | ProstRcision® | - | - | Aug-09 | |||||
Nov-03 | 64 | 6.0 | 6 | T1c | Brachytherapy | 0.30
| Diet;exercise
| Jul-08 | |||||
Feb-03 | 55 | 6.9 | 6 | T1c | Brachytherapy | 0.06 | - | Aug-09 | |||||
| Nov-97 |
59 |
5.6 |
7 |
T1c |
Brachy/EBRT |
0.10 |
None |
Jan-08 | |||||
Feb-07 | 70 | 3.97 | 6 | T2a | Brachy
+ IMRT |
No
response to reminder | Aug-08 | ||||||
|
Dec-03 |
56 |
21.0 |
9 |
T2c |
Brachytherapy |
0.85 |
- |
Jan-09 | |||||
Mar-09 | 50 | 5.81 | 7 | T1c | Brachytherapy | 1.37 | No
problems | Jan-10 | |||||
| Jul-99 |
55 |
8.9 |
6 |
T1c |
HDR Brachy/EBRT |
8.3 |
None |
Mar-09 | |||||
| Oct-02 |
70 |
8.0 |
6 |
T1c |
Brachytherapy |
Passed
On - RIP | Apr-05 | ||||||
Jul-07 | 67 | 5.29 | 7 | T2a | Brachytherapy | No
response to reminder | Sep-07 | ||||||
Apr-09 | 71 | 5.9 | 6 | T1c | Brachytherapy | 0.86 | - | Nov-09 | |||||
Oct-09 | 57 | 9.4 | 6 | T1c | Brachytherapy | - | - | Jan-10 | |||||
| Dec-07 |
68 |
<4.0 |
9 |
T3 |
ADT/EBRT/HDR
Brachy | 0.10 |
-
| Jan-09 | |||||
| Mar-05 |
58 |
4.0 |
6 |
T2b |
Brachytherapy |
0.10 |
-
| May-09 | |||||
|
Apr-08 |
62 |
3.39 |
7 |
T1c |
ADT/IMRT/Brachy |
Undetect |
ADT |
Aug-08 | |||||
Jun-09 | 65 | 4.7 | 6 | T2a | Brachytherapy | 1.4 | Urinary/bowel
problems | Jan-10 | |||||
| Dec-07 |
48 |
4.3 |
6 |
T1c |
Brachytherapy |
Undetect |
Surgery/ADT
| Jul-09 | |||||
Jun-08 | 61 | 4.8 | 6 | T1c | Brachytherapy
(SI) | 2.37 | - | May-09 | |||||
Mar-07 | 67 | 11.3 | 6 | T1c | Brachytherapy | 3.0 | - | Nov-08 | |||||
| Mar-97 |
59 |
4.5 |
5 |
T1c |
ADT/Brachy(HDR) |
Undet. |
None |
Dec-09 | |||||
Oct-06 | 51 | 36.6 | 6 | T1c | ProstRcision® | 0.08 | None | Jan-10 | |||||
| Aug-99 |
57 |
4.4 |
6 |
T1c |
Brachytherapy/ADT |
0.06 |
-
| May-09 | |||||
Jul-06 | 52 | 1.9 | 6 | T2a | Brachytherapy | <1.0 | - | Nov-09 | |||||
| Jun-06 |
55 |
34.0 |
9 |
T2c |
ADT/HDR
Brachy/EBRT |
105.0 |
Clinical
trial | Jan-10 | |||||
Aug-07 | 68 | 5.2 | 6 | T1c | Brachytherapy/IMRT | 0.30 | - | Aug-09 | |||||
Apr-07 | 50 | 4.1 | 6 | T1c | HDR
Brachytherapy | 1.8 | - | Jan-09 | |||||
| Jan-08 |
68 |
4.7 |
7 |
T1c |
Brachytherapy |
0.15 |
ADT |
Jan-10 | |||||
| Aug-04 |
44 |
27.0 |
? |
T1c |
Brachytherapy |
1.99 |
Hormone |
Dec-08 | |||||
|
Nov-04 |
58 |
10.4 |
6 |
T1b |
Brachytherapy |
0.10 |
No
problems |
Jan-10 | |||||
| Dec-09 |
72 |
0.30 |
7 |
T2a |
Brachytherapy |
- |
- |
Jan-10 | |||||
| Jul-08 |
64 |
5.8 |
6 |
T1c |
HDR
Brachytherapy | 0.90 |
Daily
Cialis for ED |
Dec-09 | |||||
| Dec-04 |
66 |
6.1 |
6 |
T1c |
Brachytherapy | 0.03 |
- |
Jun-09 | |||||
May-07 | 59 | 115.0 | 7 | T2a | ADT/Brachytherapy | 4.2 | EBRT | Oct-09 | |||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
CRYOTHERAPY | |||||||||||||
Apr-93 | 57 | 6.3 | 7 | T1c | Cryotherapy | <0.01 | Proton
Beam | Mar-09 | |||||
Jan-94 | 65 | 6.8 | 7 | T2b | Cryotherapy | 0.34 | ADT/Supplements
| Aug-09 | |||||
Jan-08 | 56 | 5.6 | 8 | T2 | Cryotherapy |
No
response to reminder | Jun-08 | ||||||
Apr-07 | 71 | 4.7 | 6 | T2 | Cryotherapy | 2.6 | AS/EBRT | Sep-09 | |||||
Jan-04 | 65 | 2.99 | 6 | T2c |
Cryotherapy | No
response to reminder | May-06 | ||||||
Aug-05 | 58 | 9.1 | 7 | T2a | Cryotherapy | 0.01 | - | Jul-09 | |||||
Mar-06 | 64 | 4.6 | 6 | T1c | Focal
Cryotherapy | ? | No
problems | Dec-09 | |||||
May-07 | 58 | 2.5 | 6 | T2a | Focal
Cryotherapy | 2.85 | Therapy
Failed/AS | Nov-09 | |||||
|
Primary
Treatment
|
Further
treatment, if any, with current PSA |
Name | |||||||||||
|
Date |
Age |
PSA |
GS |
Stage |
PSA |
Treatment/SideEffects
| Date | ||||||
RADIATION
- EBRT - EXTERNAL BEAM RADIATION THERAPY | |||||||||||||
Jun-07 | 61 | 24.0 | 7 | T3b | ADT/EBRT | - | - | Aug-09 | |||||
Jan-05 | 47 | 31.19 | 7 | T1c | EBRT/ADT | 1.06 | Inter
ADT | Aug-09 | |||||
Jan-09 | 70 | 114.0 | 7 | T2 |
ADT/EBRT | - | - | Feb-09 | |||||
| Dec-04 |
48 |
11.6 |
9 |
T2c |
ADT/EBRT |
0.32 |
Intermit
ADT |
Oct-09 | |||||
| Dec-96 |
68 |
145.0 |
7 |
T4 |
EBRT |
60 ish |
Chemotherapy |
Apr-09 | |||||
|
Mar-09 |
63 |
5.9 |
7 |
T1c |
ADT/EBRT |
0.20 |
- |
Dec-09 | |||||
May-05 | 59 | 19.0 | 7 | T2c | ADT/EBRT | Passed
On - RIP | Jan-09 | ||||||
Apr-07 | 73 | 7.9 | 7 | T1c | ADT/EBRT/Brachy | 0.02 | - | Jun-09 | |||||
Nov-09 | 64 | 5.4 | 6 | T1c | EBRT | - | - | Dec-09 | |||||
Dec-08 | 60 | 1.9 | 9 | T2 | ADT/EBRT | Undetec |
ADT | Jan-10 | |||||
Jul-08 | 76 | 1.4 | 10 | T2 | ADT/IMRT | - | - | Nov-08 | |||||
Nov-07 | 65 | 20.2 | 6 | T3 | ADT/EBRT | 0.10 | No
problems reported | Jan-10 | |||||
Dec-04 | 70 | 10.5 | 7 | T1c | EBRT | 3.2 | - | Aug-09 | |||||
|
Apr-94 |
76 |
15.0 |
6 |
T2b |
Radiation/Cryo/ADT |
Passed
On - RIP | Jun-07 | ||||||
Jan-07 | 61 | 48.0 | ? | ? | ADT/EBRT | - | - | Dec-08 | |||||
Oct-98 | 72 | 27.4 | 7 | T3b | ADT/EBRT | 14.0 | Inter
ADT | Oct-09 | |||||
May-07 | 70 | 12.2 | 6 | T1c | ADT/EBRT | 0.01 | Inter
ADT | Sep-09 | |||||
Nov-08 | 68 | 11.2 | 5 | T1c | ADT/EBRT | - | - | Aug-09 | |||||
Jun-09 | 53 | 4.7 | 7 | T1c | ADT/EBRT | - | - | Nov-09 | |||||
Dec-06 | 62 | 4.2 | 7 | T2b |
IMRT | 0.60 | - | Jan-09 | |||||
Nov-07 | 50 | 66.04 | 7 | T3b |
ADT/EBRT | 0.54 | Intermit
ADT | Feb-09 | |||||
Feb-09 | 60 | 5.8 | 7 | T1c | EBRT
- IGRT | 0.76 | - | Aug-09 | |||||
May-07 | 75 | 7.7 | 7 | T2 | ADT/EBRT | 0.26 | ADT | Jul-09 | |||||
| Jul-00 |
62 |
21.5 |
6 |
T1c |
ADT/ProstRcision© |
0.10 |
Flomax |
Oct-09 | |||||
Mar-09 | 65 | 39.0 | 7 | T2a | EBRT
| 0.20 | - | Aug-09 | |||||
Jul-05 | 53 | 7.6 | 7 | ? | IMRT | 0.10 | ADT | Sep-08 | |||||
Apr-02 | 62 | 5.2 | 7 | T2b | ADT/EBRT/Brachy |
No
response to reminder | Jun-08 | ||||||
Sep-08 | 65 | 3.2 | 7 | T1c | EBRT-Cyberknife© | 0.90 | No
problems | Jan-10 | |||||
Aug-05 | 48 | 3.6 | 6 | T1c |
IMRT | 1.3 | - | Aug-09 | |||||
Nov-02 | 67 | 7.5 | 6 | T1c | EBRT | 0.96 | - | Jul-09 | |||||
Dec-06 | 54 | 60.0 | 6 | T1c | EBRT | 1.3 | Intermit
ADT | Aug-09 | |||||
Aug-94 | 70 | 19.0 | 9 | T1c | EBRT/ADT | 14.3 | ADT | Oct-09 | |||||
Sep-96 | 57 | 25.4 | 7 | T2c | ADT/EBRT/HIFU |
No
response to reminder | Jun-08 | ||||||
Oct-07 | 54 | 34.0 | 7 | T1c | EBRT | 1.3 | - | Sep-09 | |||||
Dec-08 | 56 | 377.0 | 8 | T3 | ADT/EBRT | 0.864 | - | Jun-09 | |||||
Jun-09 | 70 | 7.8 | 7 | T1c | ADT/EBRT(IGRT) | 2.5 | - | Dec-09 | |||||
Jun-07 | 51 | 19.5 | 7 | T2 | ADT/IMRT/Brachy
HDR | 6.14 | Estrogen | Aug-09 | |||||
Apr-05 | 54 | 182.0 | 6 | T4 | ADT/EBRT | 2.35 |
Inter ADT/Diet | Oct-09 | |||||
Nov-07 | 69 | 37.8 | 9 | T1c | ADT/EBRT | <0.10 | ADT | Aug-09 | |||||
Jan-08 | 53 | 6.7 | 7 | T1c | ADT/EBRT | Undetec | ADT | Nov-09 | |||||
Jul-06 | 72 | 24.0 | 10 | T3 | ADT/Radiation | 13.1 | ADT | Mar-09 | |||||
Jan-09 | 59 | 53.0 | 7 | T1c | EBRT(IMRT) | 0.30 | Inter
ADT | Dec-09 | |||||
Dec-97 | 63 | 4.4 | 9 | T1b | ADT/EBRT/Brachy | <0.03 | Diet:
Exercise | Aug-09 | |||||
Jun-09 | 56 | 4.6 | 7 | T2a | EBRT/IMRT | - | - | Oct-09 | |||||
May-07 | 56 | 76.41 | 9 | T3b | EBRT/ADT | <0.01 | Intermit
ADT | ||||||